Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System
- PMID: 33384690
- PMCID: PMC7770166
- DOI: 10.3389/fimmu.2020.596631
Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System
Abstract
COVID-19 is a distinctive infection characterized by elevated inter-human transmission and presenting from absence of symptoms to severe cytokine storm that can lead to dismal prognosis. Like for HIV, lymphopenia and drastic reduction of CD4+ T cell counts in COVID-19 patients have been linked with poor clinical outcome. As CD4+ T cells play a critical role in orchestrating responses against viral infections, important lessons can be drawn by comparing T cell response in COVID-19 and in HIV infection and by studying HIV-infected patients who became infected by SARS-CoV-2. We critically reviewed host characteristics and hyper-inflammatory response in these two viral infections to have a better insight on the large difference in clinical outcome in persons being infected by SARS-CoV-2. The better understanding of mechanism of T cell dysfunction will contribute to the development of targeted therapy against severe COVID-19 and will help to rationally design vaccine involving T cell response for the long-term control of viral infection.
Keywords: CD4 exhaustion; COVID-19; HIV; cytokine storm; leaky gut.
Copyright © 2020 Peng, Ouyang, Isnard, Lin, Fombuena, Zhu and Routy.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
